Amboy Street Ventures

Amboy Street Ventures is the world’s first venture capital fund dedicated exclusively to Women’s Health and Sexual Wellbeing for all genders. Founded in 2020 and headquartered in Los Angeles, California, the firm focuses on investing in innovative startups that address critical but underserved areas such as fertility, menopause, maternal health, LGBTQ+ health, menstruation, hormonal health, sexual health, and contraception. The fund targets the untapped $1 trillion global women’s health market by supporting cutting-edge technologies and products that improve health outcomes and wellbeing.

The firm primarily invests in Seed and Series A rounds, backing companies that are advancing the industry in America and Europe. Amboy Street Ventures is an active investor that adds value beyond capital through its Value Enhancement Team, which supports portfolio companies in marketing, branding, sales, product development, scientific innovation, and public education. Their portfolio includes diverse startups such as Evvy (vaginal microbiome care), Contraline (non-hormonal male birth control), HeyJane (digital abortion clinic), and Millie (modern maternity clinics).

Amboy Street Ventures was founded by Carli Sapir, who leads the investment team and brings a personal passion for women’s health innovation. The team includes partners with expertise in private equity, medicine, sexual health, and marketing. The fund is named after the historic Amboy Street Birth Control Clinic in Brooklyn, symbolizing its commitment to advancing accessible and inclusive health solutions. With a focus on health equity and social reformation, Amboy Street Ventures aims to bridge the funding gap that has historically limited innovation in women’s and sexual health sectors.